Parabolan – 100 mg

Parabolan 100 mg is an injectable preparation historically associated with trenbolone hexahydrobenzylcarbonate, a long-acting ester of trenbolone. The “100 mg” designation typically refers to 100 mg of active compound per milliliter of sterile oil-based solution. Parabolan was originally developed for medical use but is no longer widely manufactured by major pharmaceutical companies.

Active Ingredient

Trenbolone Hexahydrobenzylcarbonate is a potent anabolic-androgenic compound derived from nandrolone. The hexahydrobenzylcarbonate ester allows for a slow and sustained release of trenbolone following intramuscular injection, resulting in a prolonged duration of action compared to shorter esters.

Composition

A typical formulation may include:

• Trenbolone Hexahydrobenzylcarbonate – 100 mg

• Pharmaceutical-grade carrier oil (such as sesame oil or similar)

• Preservatives and solvents, commonly benzyl alcohol and/or benzyl benzoate

Exact ingredients and concentrations depend on the manufacturer.

Mechanism of Action

Trenbolone binds strongly to androgen receptors in muscle and other tissues. It enhances protein synthesis, improves nitrogen retention, and may stimulate red blood cell production. Trenbolone is considered highly potent in both anabolic and androgenic activity relative to many other anabolic agents.

Medical and Regulatory Context

Parabolan was previously prescribed in certain clinical settings but is not widely approved for human use today. Trenbolone compounds are often classified as controlled substances in many countries, and unauthorized possession or distribution may be illegal.

Safety Information

Potential risks include suppression of natural hormone production, changes in cholesterol levels, elevated blood pressure, mood disturbances, and increased cardiovascular strain. Use should only occur under proper legal and professional supervision where permitted.